Suppr超能文献

轻度与重度肾衰竭患者经皮冠状动脉介入治疗后的有效性及不良事件

Effectiveness of and adverse events after percutaneous coronary intervention in patients with mild versus severe renal failure.

作者信息

Rubenstein M H, Sheynberg B V, Harrell L C, Schunkert H, Bazari H, Palacios I F

机构信息

Cardiac Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.

出版信息

Am J Cardiol. 2001 Apr 1;87(7):856-60. doi: 10.1016/s0002-9149(00)01526-5.

Abstract

Patients with renal failure undergoing percutaneous coronary intervention (PCI) experience reduced procedural success rates and increased in-hospital and long-term follow-up major adverse cardiac events. This study was designed to determine whether the severity of preprocedural renal failure influences the outcomes of patients with renal failure undergoing PCI. We compared the immediate and long-term outcomes of 192 patients with mild renal failure (creatinine 1.6 to 2.0 mg/dl, mean 1.76) with those of 131 patients with severe renal failure (creatinine >2.0 mg/dl, mean 2.90), selected from 3,334 consecutive patients undergoing PCI between 1994 and 1997. Although the overall population with renal failure represents a high-risk group, the severe renal failure cohort had a higher incidence of hypertension, multivessel disease, prior coronary bypass surgery, vascular disease, and congestive heart failure (all p values <0.05), yet had similar angiographic characteristics. Procedural success was higher in the group with severe renal failure (93.7% vs 87.7%, p = 0.04). There were no statistically significant differences in in-hospital mortality (11.5% vs 9.9%, p = 0.7), Q-wave myocardial infarction (0.5% vs 0%, p = 0.4), emergent bypass surgery (0% vs 0%, p = 1.0), and in-hospital major adverse cardiac events (11.5% vs 9.9%, p = 0.7) between the mild and severe renal groups, respectively. Kaplan-Meier analyses showed no statistically significant difference in long-term survival (log rank test, p = 0.1) or event-free survival (log rank test, p = 0.3) between the 2 groups. Finally, creatinine was not identified as an independent predictor of in-hospital or long-term follow-up major adverse cardiac events. In our high-risk population, patients with mild renal insufficiency undergoing PCI experience major adverse outcomes in the hospital and at long-term follow-up similar to those of patients with severe renal failure.

摘要

接受经皮冠状动脉介入治疗(PCI)的肾衰竭患者手术成功率降低,住院期间及长期随访的主要不良心脏事件增加。本研究旨在确定术前肾衰竭的严重程度是否会影响接受PCI的肾衰竭患者的预后。我们比较了192例轻度肾衰竭患者(肌酐1.6至2.0mg/dl,平均1.76)和131例重度肾衰竭患者(肌酐>2.0mg/dl,平均2.90)的近期和远期预后,这些患者选自1994年至1997年间连续接受PCI的3334例患者。虽然总体肾衰竭人群属于高危组,但重度肾衰竭队列中高血压、多支血管病变、既往冠状动脉搭桥手术、血管疾病和充血性心力衰竭的发生率更高(所有p值<0.05),不过血管造影特征相似。重度肾衰竭组的手术成功率更高(93.7%对87.7%,p = 0.04)。轻度和重度肾衰竭组之间在住院死亡率(11.5%对9.9%,p = 0.7)、Q波心肌梗死(0.5%对0%,p = 0.4)、急诊搭桥手术(0%对0%,p = 1.0)以及住院期间主要不良心脏事件(11.5%对9.9%,p = 0.7)方面均无统计学显著差异。Kaplan-Meier分析显示两组之间在长期生存率(对数秩检验,p = 0.1)或无事件生存率(对数秩检验,p = 0.3)方面无统计学显著差异。最后,肌酐未被确定为住院期间或长期随访主要不良心脏事件的独立预测因素。在我们的高危人群中,接受PCI的轻度肾功能不全患者在住院期间及长期随访中的主要不良结局与重度肾衰竭患者相似。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验